| Literature DB >> 26347328 |
Wilhelmina Ekström1, Bodil Samuelsson2, Sari Ponzer3, Tommy Cederholm4, Karl-Göran Thorngren5, Margareta Hedström6.
Abstract
OBJECTIVES: To evaluate potential sex differences and other factors associated with complications within 4 months after a hip fracture.Entities:
Keywords: associated factors; complications; hip fracture; male sex
Mesh:
Year: 2015 PMID: 26347328 PMCID: PMC4531035 DOI: 10.2147/CIA.S80100
Source DB: PubMed Journal: Clin Interv Aging ISSN: 1176-9092 Impact factor: 4.458
Baseline demographics in 1,915 patients aged >65 years with a hip fracture
| Women
| Men
| ||||
|---|---|---|---|---|---|
| N | % | N | % | ||
| Age, mean (SD) | 84 (6.8) | 82 (7.4) | 65–101 | <0.001 | |
| Residence | |||||
| Own home | 1,077 | 76 | 373 | 80 | 0.153 |
| Institution | 334 | 24 | 96 | 20 | |
| Activities of daily living | |||||
| Katz A–B | 986 | 73 | 312 | 70 | 0.138 |
| Katz C–G | 357 | 27 | 135 | 30 | |
| Type of fracture | |||||
| Cervical | 668 | 48 | 255 | 53 | 0.004 |
| Pertrochanteric | 655 | 46 | 181 | 38 | |
| Subtrochanteric | 92 | 6 | 44 | 9 | |
| ASA score | |||||
| ASA 1–2 | 557 | 39 | 147 | 31 | 0.002 |
| ASA 3–4 | 872 | 61 | 328 | 69 | |
| Number of comorbidities | |||||
| Mean, (SD), median | 1.4 (0.96) | 1 | 1.6 (1.08) | 2 | <0.001 |
| 0–1 | 847 | 60 | 230 | 48 | |
| ≥2 | 568 | 40 | 247 | 52 | <0.001 |
| Specific comorbidity | |||||
| Cardiovascular disease | 951 | 67 | 317 | 66 | 0.824 |
| Stroke | 230 | 14 | 94 | 22 | <0.001 |
| Pulmonary disease | 206 | 15 | 97 | 20 | 0.002 |
| Renal disease | 52 | 4 | 28 | 6 | 0.038 |
| Diabetes | 156 | 11 | 66 | 14 | 0.097 |
| Rheumatoid arthritis | 100 | 7 | 25 | 5 | 0.169 |
| Parkinson’s disease | 37 | 3 | 23 | 5 | 0.017 |
| Malignancy | 198 | 14 | 100 | 21 | <0.001 |
| Cognitive dysfunction | 775 | 58 | 262 | 59 | 0.594 |
| Pressure ulcer at admission | |||||
| Grade I | 54 | 4 | 14 | 3 | 0.392 |
| Grade II–IV | 52 | 4 | 17 | 4 | 0.944 |
| Surgery same day or day after admission | 1,092 | 76 | 357 | 74 | 0.446 |
Notes:
Chi-square tests (one-way ANOVA for mean age), women vs men.
Missing: 35;
missing: 125;
missing: 20;
missing: 11;
missing: 23;
according to SPMSQ (0–7).
Abbreviations: ASA, American Society of Anesthesiologists; SD, standard deviation; SPMSQ, Short Portable Mental Status Questionnaire; ANOVA, analysis of variance.
Complications 0–4 months after a hip fracture in 1,915 patients aged ≥65 years
| Women
| Men
| ||||
|---|---|---|---|---|---|
| N | % | N | % | ||
| Number of complications | |||||
| None | 613 | 44 | 194 | 42 | 0.119 |
| One | 500 | 35 | 156 | 33 | |
| Two or more | 290 | 21 | 118 | 25 | |
| Type of complication | |||||
| Pressure ulcer | 248 | 18 | 96 | 20 | 0.200 |
| Urinary tract infection | 435 | 30 | 109 | 23 | 0.001 |
| Cardiac complication | 191 | 13 | 85 | 18 | 0.018 |
| Pneumonia | 79 | 6 | 65 | 14 | <0.001 |
| Wound infection, superficial | 69 | 5 | 16 | 3 | 0.174 |
| Wound infection, deep | 24 | 2 | 9 | 2 | 0.768 |
| Acute renal failure | 32 | 2 | 10 | 2 | 0.416 |
| Gastrointestinal bleeding | 27 | 2 | 9 | 2 | 0.993 |
| Myocardial infarction | 49 | 3 | 18 | 4 | 0.729 |
| Cerebrovascular lesion | 27 | 2 | 11 | 2 | 0.577 |
| Pulmonary embolism | 14 | 1 | 5 | 1 | 0.899 |
| Deep venous thrombosis | 17 | 1 | 4 | 1 | 0.899 |
| Mortality | |||||
| Mortality, 30 days | 136 | 10 | 74 | 15 | <0.001 |
| Mortality, 0–4 months | 207 | 14 | 116 | 24 | <0.001 |
Notes:
All P-values chi-square tests, women vs men.
Pressure ulcers grade I–IV developed during hospital stay.
Crude effect of preoperative variables on pressure ulcer, cardiac complication, and pneumonia
| Binary variable | Pressure ulcer
| Cardiac complication
| Pneumonia
| ||||||
|---|---|---|---|---|---|---|---|---|---|
| OR | (95% CI) | OR | (95% CI) | OR | (95% CI) | ||||
| Sex, male vs female | 1.2 | (0.9–1.6) | 0.2 | 1.4 | (1.1–1.9) | 0.016 | 2.7 | (1.9–3.8) | <0.001 |
| Age, 85–103 vs 65–84 | 1.4 | (1.1–1.8) | 0.003 | 1.3 | (1.0–1.6) | 0.06 | 1.2 | (0.8–1.7) | 0.3 |
| Residence, institutional vs own home | 1.4 | (1.1–1.8) | 0.012 | 0.8 | (0.6–1.6) | 0.3 | 1.2 | (0.8–1.8) | 0.3 |
| ADL, assisted vs independent | 1.6 | (1.2–2.0) | 0.001 | 0.9 | (0.7–1.2) | 0.5 | 1.4 | (0.9–2.0) | 0.09 |
| Fracture type, extracapsular vs intracapsular | 1.2 | (1.0–1.5) | 0.1 | 0.9 | (0.7–1.1) | 0.3 | 1.1 | (0.8–1.5) | 0.7 |
| ASA classification, 3–4 vs 1–2 | 1.4 | (1.1–1.8) | 0.013 | 2.2 | (1.6–3.0) | <0.001 | 2.5 | (1.6–3.7) | <0.001 |
| Time to surgery, 0–1 day vs 2 or more days | 1.6 | (1.3–2.1) | <0.001 | 1.7 | (1.3–2.3) | <0.001 | 1.5 | (1.0–2.1) | 0.045 |
| Cardiovascular disease | 1.1 | (0.9–1.4) | 0.42 | 2.6 | (1.9–3.5) | <0.001 | 1.1 | (0.8–1.6) | 0.7 |
| Stroke | 1.0 | (0.8–1.4) | 0.9 | 1.1 | (0.8–1.5) | 0.7 | 1.1 | (0.7–1.7) | 0.7 |
| Pulmonary disease | 1.5 | (1.1–2.0) | 0.006 | 2.1 | (1.5–2.8) | <0.001 | 2.7 | (1.9–3.9) | <0.001 |
| Renal disease | 1.2 | (0.7–2.0) | 0.6 | 1.5 | (0.9–2.6) | 0.6 | 1.2 | (0.5–2.7) | 0.6 |
| Diabetes | 0.8 | (0.6–1.2) | 0.4 | 1.2 | (0.8–1.8) | 0.3 | 1.1 | (0.6–1.7) | 0.9 |
| Rheumatoid arthritis | 0.8 | (0.5–1.3) | 0.3 | 1.2 | (0.7–2.0) | 0.4 | 1.1 | (0.6–2.1) | 0.8 |
| Parkinson’s disease | 1.4 | (0.8–2.6) | 0.3 | 0.8 | (0.4–1.7) | 0.5 | 1.9 | (0.9–4.2) | 0.08 |
| Malignancy | 1.3 | (1.0–1.8) | 0.065 | 1.3 | (1.0–1.9) | 0.08 | 1.3 | (0.8–2.0) | 0.3 |
| Cognitive function, | 1.5 | (1.2–2.0) | 0.001 | 1.6 | (1.2–2.1) | 0.002 | 2.4 | (1.6–3–6) | <0.001 |
| Number of complications, 2 or more vs 1 | 1.6 | (1.2–2.0) | <0.001 | 2.6 | (1.8–3.1) | <0.001 | 3.1 | (2.0–4.7) | <0.001 |
| Mortality within 30 days, yes vs no | 2.0 | (1.5–2.8) | <0.001 | 3.9 | (2.9–5.4) | <0.001 | 2.6 | (1.7–3.9) | <0.001 |
| Mortality 0–4 months, yes vs no | 1.6 | (1.2–2.2) | 0.001 | 2.5 | (1.8–3.3) | <0.001 | 2.2 | (1.5–3.2) | <0.001 |
Notes: All P-values chi-square tests.
Variables still significant after adjusting for associated baseline variables.
According to the Short Portable Mental Status Questionnaire (0–7 vs 8–10).
Reference group.
Abbreviations: ASA, American Society of Anesthesiologists; ADL, activities of daily living; CI, confidence interval; OR, odds ratio.
Logistic regression models of baseline variables associated with the most frequent complications
| Urinary tract infection
| Pressure ulcer
| Cardiac complication
| Pneumonia
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OR | (95% CI) | OR | (95% CI) | OR | (95% CI) | OR | (95% CI) | |||||
| Sex | ||||||||||||
| Female | 1 | 1 | ||||||||||
| Male | 0.7 | (0.5–0.9) | 0.003 | 2.4 | (1.7–3.6) | <0.001 | ||||||
| Age | ||||||||||||
| 65–84 | 1 | 1 | ||||||||||
| >85 | 1.2 | (0.0–1.5) | 0.034 | 1.4 | (1.1–1.8) | 0.008 | ||||||
| ADL | ||||||||||||
| Independent | 1 | |||||||||||
| Dependent (Katz C–G) | 1.6 | (1.2–2.1) | 0.001 | |||||||||
| Time-to-surgery | ||||||||||||
| 0–1 day | 1 | 1 | ||||||||||
| 1 days | 1.6 | (1.2–2.1) | <0.001 | 1.6 | (1.2–2.2) | 0.001 | ||||||
| Cardiovascular disease | ||||||||||||
| No | 1 | |||||||||||
| Yes | 2.2 | (1.5–3.0) | <0.001 | |||||||||
| Pulmonary disease | ||||||||||||
| No | 1 | 1 | 1 | |||||||||
| Yes | 1.6 | (1.2–2.2) | 0.003 | 2.0 | (1.4–2.8) | <0.001 | 2.8 | (1.8–4.2) | <0.001 | |||
| Cognitive function | ||||||||||||
| Normal (SPMSQ | 1 | 1 | ||||||||||
| Dysfunction (SPMSQ 0–7) | 1.5 | (1.1–2.0) | 0.006 | 2.5 | (1.6–3.8) | <0.001 | ||||||
Notes:
The SPMSQ.
Reference variable.
Abbreviations: ADL, activities of daily living; CI, confidence interval; OR, odds ratio; SPMSQ, Short Portable Mental Status Questionnaire.